Aarti Drugs Q2 Results
- BSE: 524348
- NSE: AARTIDRUGS
- ISIN: INE767A01016
- Sector: Biotechnology & Drugs
BSE
453.7
4.70 (1.05%)
4.70 (1.05%)Volume5.95 K
Updated: Mon 25 Nov, 2024 | 15:52:55
NSE
453.13.85 (0.86%)
3.85 (0.86%)Volume1.36 L
Updated: Mon 25 Nov, 2024 | 15:31:33
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹598.33 Cr.(7.74%)
- Operating Profit₹53.32 Cr.(3.37%)
- Profit After Tax₹35.01 Cr.(5.31%)
- Operating Margin8.91%(-10.43%)
Note: Comparison is on YoY basis
Quarterly - Aarti Drugs Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 598.33 | 661.11 | -% | 641.54 | -% |
| Selling/ General/ Admin Expenses Total | 26.56 | 25.47 | -% | 25.45 | -% |
| Depreciation/ Amortization | 13.72 | 12.60 | -% | 12.61 | -% |
| Other Operating Expenses Total | 110.73 | 105.21 | -% | 110.62 | -% |
| Total Operating Expense | 545.01 | 589.63 | -% | 577.71 | -% |
| Operating Income | 53.32 | 71.48 | -% | 63.83 | -% |
| Net Income Before Taxes | 45.88 | 63.53 | -% | 56.27 | -% |
| Net Income | 35.01 | 47.84 | -% | 39.60 | -% |
| Diluted Normalized EPS | 3.83 | 5.18 | -% | 4.29 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST